Archive
Analyses on Medtech
2 articles — sorted by date
Medtronic: Strong Quarter, Solid Value, but No 15% Return
Without MiniMed, Medtronic grows at double digits and earns 9.6% on capital. Fair value ~$110, but my 15% hurdle needs an entry below $89.
MiniMed: A Good Split-off Setup, but No Margin of Safety Yet
Medtronic is out and 90% of MiniMed shares sit with exchangers under water. The margin bet only pays for me below $16.70.